Merck's Record High Valuation Rises Above Market Norms

The recent market has seen 17 Large Cap stocks reach new 52-week highs, including Merck (MRK), which leads the list with a market value of approximately $335.8 billion.

The list is dominated by Financials sector stocks, with six names from the Diversified Banks industry and two from Asset Management & Custody Banks.

However, Merck's valuation stands out, trading at 105.7 times trailing earnings despite a 4.6% revenue growth over the last twelve months and an operating margin of 10.5%.

The market is pricing these new highs differently, with companies like Charles Schwab (SCHW) and Royal Bank of Canada (RY) trading at multiples of 19.1 and 13.6 times trailing earnings, respectively.